Hunan Hansen Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 955.53 million compared to CNY 916.06 million a year ago. Net income was CNY 205.01 million compared to CNY 167.62 million a year ago.

Basic earnings per share from continuing operations was CNY 0.4074 compared to CNY 0.3331 a year ago. Diluted earnings per share from continuing operations was CNY 0.4074 compared to CNY 0.3331 a year ago.